Profile data is unavailable for this security.
About the company
NeuroScientific Biopharmaceuticals Limited is an Australia-based company, which is engaged in developing peptide-based pharmaceutical drugs that target a number of neurodegenerative conditions with high unmet medical demand. The Company's product portfolio includes EmtinB, a therapeutic peptide initially targeting glaucoma, as well as other Emtin peptides (EmtinAc, EmtinAn and EmtinBn). EmtinB is a peptide-based compound that binds to surface-based cell receptors from the LDLR family, activating intracellular signalling pathways that stimulate neuroprotection, neuroregeneration and modulate neuroinflammation. EmtinB is modelled on a specific active domain of the complex human protein called Metallothionein-IIA, which is produced as part of the human body's innate immune response to cell injury. Its StemSmart is a global patented technology engaged in manufacturing cell products. The use of its proprietary StemSmart technology in a special access program for fistulising Crohn’s disease.
- Revenue in AUD (TTM)166.08k
- Net income in AUD-1.85m
- Incorporated2002
- Employees--
- LocationNeuroScientific Biopharmaceuticals LtdSuite 5, 85 Forrest St, CottesloeNEDLANDS 6011AustraliaAUS
- Phone+61 86382-1800
- Fax+61 86382-1801
- Websitehttps://neuroscientific.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Noxopharm Ltd | 2.83m | -4.88m | 23.38m | 1.00k | -- | 33.88 | -- | 8.26 | -0.0167 | -0.0167 | 0.0097 | 0.0024 | 0.4979 | -- | 1.06 | -- | -85.95 | -49.70 | -156.33 | -59.16 | -- | -- | -172.63 | -229.01 | -- | -- | 0.7823 | -- | 17.54 | -19.45 | -36.50 | -- | -- | -- |
| BTC Health Ltd | 9.96k | 3.98m | 24.31m | 1.00 | 5.84 | 2.42 | 6.11 | 2,440.45 | 0.0117 | 0.0117 | 0.00003 | 0.0282 | 0.0014 | -- | -- | -- | 54.89 | -13.71 | 56.47 | -14.66 | -- | -- | 39,972.79 | -3,966.34 | -- | -- | 0.00 | -- | -39.12 | -43.28 | 277.27 | -- | -- | -- |
| Holista Colltech Limited | 5.83m | 584.85k | 28.69m | 3.00 | 35.45 | -- | 44.37 | 4.92 | 0.0022 | 0.0023 | 0.0195 | -0.0016 | 1.76 | 3.83 | 5.84 | -- | 17.53 | -46.13 | -- | -85.40 | 49.66 | 55.15 | 9.98 | -38.85 | 0.3782 | 3.93 | -- | -- | -5.82 | -5.07 | 97.92 | -- | -37.01 | -- |
| Algorae Pharmaceuticals Ltd | 141.05k | -802.96k | 35.46m | -- | -- | 15.90 | -- | 251.44 | -0.0005 | -0.0005 | 0.00008 | 0.0013 | 0.0505 | -- | 3.38 | -- | -28.72 | -51.95 | -30.63 | -56.76 | -- | -- | -569.27 | -1,452.78 | -- | -- | 0.00 | -- | 12.66 | -23.93 | 61.68 | -- | -- | -- |
| Argenica Therapeutics Ltd | 332.69k | -9.80m | 35.97m | -- | -- | 10.45 | -- | 108.11 | -0.0762 | -0.0762 | 0.0026 | 0.0268 | 0.0323 | -- | 1.79 | -- | -95.10 | -47.11 | -117.81 | -55.90 | -- | -- | -2,945.67 | -2,938.71 | -- | -40,666.84 | 0.00 | -- | 166.93 | 359.61 | -30.86 | -- | -- | -- |
| Anteotech Ltd | 1.03m | -6.76m | 41.62m | 40.00 | -- | 12.02 | -- | 40.50 | -0.0025 | -0.0025 | 0.0004 | 0.0012 | 0.1299 | -- | 6.90 | -- | -85.41 | -76.84 | -106.22 | -87.65 | -- | -- | -657.69 | -1,253.69 | -- | -- | 0.3835 | -- | 99.60 | 27.97 | 23.89 | -- | -4.02 | -- |
| Neuroscientific Biopharmaceuticals Ltd | 166.08k | -1.85m | 43.23m | -- | -- | 2.57 | -- | 260.33 | -0.0126 | -0.0126 | 0.0011 | 0.0506 | 0.0148 | -- | 2.17 | -- | -16.48 | -37.13 | -16.65 | -40.11 | -- | -- | -1,111.22 | -185.57 | -- | -746.17 | 0.00 | -- | -93.05 | 16.84 | -669.23 | -- | -- | -- |
| Emyria Ltd | 1.39m | -3.14m | 44.36m | -- | -- | 6.34 | -- | 31.80 | -0.0069 | -0.0069 | 0.0031 | 0.0087 | 0.2316 | -- | 40.72 | -- | -52.19 | -82.51 | -69.83 | -106.69 | 1.76 | -17.98 | -225.33 | -355.61 | -- | -22.44 | 0.1037 | -- | -36.68 | 6.60 | 72.57 | -- | -41.45 | -- |
| Entropy Neurodynamics Ltd | 1.59m | -5.33m | 50.05m | -- | -- | 7.72 | -- | 31.53 | -0.0043 | -0.0043 | 0.0012 | 0.0041 | 0.2249 | -- | 0.763 | -- | -75.55 | -- | -92.06 | -- | -- | -- | -335.91 | -- | -- | -100.79 | 0.00 | -- | -- | -10.25 | -- | -- | -26.73 | -- |
| Syntara Ltd | 7.48m | -12.26m | 57.16m | 107.00 | -- | 3.55 | -- | 7.64 | -0.0084 | -0.0054 | 0.0051 | 0.0099 | 0.4701 | -- | 2.53 | -- | -77.03 | -36.39 | -116.54 | -50.26 | -- | -- | -163.86 | -78.37 | -- | -953.38 | 0.0052 | -- | 37.80 | -9.83 | 10.31 | -- | -- | -- |
| Clever Culture Systems Ltd | 6.52m | 1.68m | 63.01m | 17.00 | 37.18 | 9.08 | 33.01 | 9.66 | 0.0008 | 0.0008 | 0.0031 | 0.0032 | 0.6975 | 0.9829 | 6.37 | -- | 18.01 | -36.73 | 22.73 | -42.00 | 77.05 | -- | 25.82 | -281.21 | 1.63 | -- | 0.2653 | -- | 397.86 | 30.08 | 145.03 | -- | 24.71 | -- |
| Amplia Therapeutics Ltd | 5.01m | -7.93m | 64.13m | 1.00 | -- | 1.49 | -- | 12.81 | -0.0204 | -0.0204 | 0.0128 | 0.0837 | 0.1705 | -- | 1.28 | -- | -27.01 | -27.37 | -28.31 | -30.38 | -- | -- | -158.46 | -180.53 | -- | -- | 0.0088 | -- | -15.01 | 156.11 | -45.93 | -- | -- | -- |
